Area of research
Rheumatology · Epidemiology
Research interest
Research interests include Medicine, Internal medicine, Antiphospholipid syndrome, Emergency department, Immunology, and Antibody.
Pregnancy outcome predictors in systemic lupus erythematosus: a systematic review and meta-analysis
The 2023 <scp>ACR</scp>/<scp>EULAR</scp> Antiphospholipid Syndrome Classification Criteria
2023 ACR/EULAR antiphospholipid syndrome classification criteria
Damage measured by Damage Index for Antiphospholipid Syndrome (DIAPS) in antiphospholipid antibody-positive patients included in the APS ACTION registry
Interference in point-of-care international normalized ratio monitoring in patients with lupus anticoagulant is correlated with anti–β2-glycoprotein I antibody titers
Point-of-care neutrophil CD64 as a rule in diagnostic test for bacterial infections in the emergency department
ERN ReCONNET points to consider for treating patients living with autoimmune rheumatic diseases with antiviral therapies and anti-SARS-CoV-2 antibody products
The added value of a European Reference Network on rare and complex connective tissue and musculoskeletal diseases: insights after the first 5 years of the ERN ReCONNET
2021 DORIS definition of remission in SLE: final recommendations from an international task force
The immunologic etiology of psychiatric manifestations in systemic lupus erythematosus: A narrative review on the role of the blood brain barrier, antibodies, cytokines and chemokines
Immunomodulation Through Low-Dose Radiation for Severe COVID-19: Lessons From the Past and New Developments
The early identification of disease progression in patients with suspected infection presenting to the emergency department: a multi-centre derivation and validation study
FRI0607 IDENTIFICATION OF UNMET NEEDS RELATED TO RARE AND COMPLEX CONNECTIVE TISSUE AND MUSCULOSKELETAL DISEASES (RCTDS) ACROSS EU: THE EXPERIENCE OF THE ERN RECONNET
Procalcitonin-guided antibiotic therapy in patients with fever in a general emergency department population: a multicentre non-inferiority randomized clinical trial (HiTEMP study)
HIBISCUS: Hydroxychloroquine for the secondary prevention of thrombotic and obstetrical events in primary antiphospholipid syndrome
Identifying patients with bacterial infections using a combination of C-reactive protein, procalcitonin, TRAIL, and IP-10 in the emergency department: a prospective observational cohort study